Meniu
Asmeninė anketa Prisijungimas ir registracija
Atgal Pagrindinis » Autorių straipsniai » Paranormal News » 2020 » Spalio » 22

Volunteer in Oxford-AstraZeneca Covid-19 Vaccine Trial DIES in Brazil

Volunteer in Oxford-AstraZeneca Covid-19 Vaccine Trial DIES in Brazil
  • 22.10.2020
  • 0.0 Reitingas
  • 428 Peržiūrų
  • Aptarti

A volunteer in the AstraZeneca and University of Oxford’s coronavirus vaccine trial has died, the country’s health authority Anvisa announced on Wednesday.

G1 Rio in Brazil confirmed the volunteer to be Dr João Pedro R. Feitosa, a 28-year-old from Rio De Janeiro.

A spokesperson from AstraZeneca declined to comment on the volunteer, citing “medical confidentiality and clinical trial regulations.”

The spokesperson added that “[a]ll significant medical events are carefully assessed by trial investigators” and “[t]hese assessments have not led to any concerns about continuation of the ongoing study.

In a statement, a spokesperson from the University of Oxford, which is developing the vaccine with AstraZeneca, said “there have been no concerns about safety of the clinical trial” after an assessment of the case in Brazil.

The independent review in addition to the Brazilian regulator have recommended that the trial should continue,” Oxford spokesperson Alexander Buxton said.

News, World, Covid-19, Vaccine

Dr João Pedro R. Feitosa (pictured), a 28-year-old from Rio De Janeiro, Brazil, was confirmed to be the volunteer who died in the Brazilian arm of AstraZeneca and the University of Oxford’s coronavirus vaccine trial

CNBC report: Oxford provided no further details on the volunteer’s death, and it’s unclear if the volunteer received the vaccine. Brazil currently has the second deadliest outbreak in the world, behind the United States, with at least 115,914 deaths, according to data compiled by Johns Hopkins University.

A source familiar with the situation told Reuters that the trial would have been suspended if the volunteer had been a part of the group getting the shot.

The news comes as the Food and Drug Administration still has a late-stage clinical trial from AstraZeneca on hold in the United States. That means the company is unable to administer second doses of its two-dose vaccine regimen to U.S. participants.

News, World, Covid-19, Vaccine

The company announced on Sept. 8 that its trial had been put on hold due to an unexplained illness in a patient in the United Kingdom. The patient is believed to have developed inflammation of the spinal cord, known as transverse myelitis. The trial has since resumed in the U.K. and other countries.

The U.S. is expected to resume the trial as early as this week after the FDA completed its review, Reuters reported Tuesday, citing four anonymous sources.

AstraZeneca is one of four drugmakers backed by the U.S. in late-stage testing for a potential vaccine. AstraZeneca’s vaccine, called AZD1222, uses genetic material from the coronavirus with a modified adenovirus. 

In July, the company published data that showed its vaccine produced a promising immune response in an early-stage trial and appeared to be well tolerated.

The vaccine produced no serious adverse events in volunteers, according to the researchers at the time. Fatigue and headache were the most commonly reported side effects, they said. Other common side effects included pain at the injection site, muscle ache, chills and a fever.

Turite savo nuomone, tapk autoriumi, prisijunk ir rašykite bloge. Dalinkitės receptais, sveikatos patarimais, nutikimais, susidūrėte su nekasdieniškais reiškiniais. Galite išversti iš užsienio kalbos, talpinkite su nuoroda. Laukiame Jūsų straipsnių, naujienų, apžvalgų ar istorijų!

Pasaulio naujienas kitaip... skaitykite Paranormal Telegram kanale. X(twitter) kanale. Jei manai, kad mano darbas yra naudingas, pasidalink, prenumeruok, padėkok ar paremk...

Niekas neišdrįso palikti komentaro.
Būkite pirmi, kurie pasidalins savo nuomonėmis su kitais.
avatar

Nemokami skelbimai

TAIP PAT SKAITYKITE:
03.12.2023 laikas 20:22 Receptai | Patiekalai Topas! Šokoladinis pyragas. Jokio kepimo, jokios želatinos ir tik 10 minučių

Greitai, lengvai ir taupiai! Neįtikėtinai skanus ir gražus pyragas, kurį patiekiau kaip šventei, taip ir tiesiog arbatai.

Skaityti daugiau

01.12.2023 laikas 22:27 Receptai | Patiekalai Varškės rageliai prie arbatos. Skanūs kepiniai be kiaušinių
Taip skanu ir greita, kad kepu kasdien! Nebrangus receptas, prieinamas visiems.

Skaityti daugiau

01.12.2023 laikas 22:00 Receptai | Patiekalai Pyragas su kefyru, mėsos įdaru. Be orkaitės ir rūpesčių
Neįprastas, sotus ir labai skanus! Švelni kefyro tešla be mielių ir glajaus. Dalinuosi receptu.

Skaityti daugiau

05.12.2023 laikas 08:44 Prabangios moters savybė, dėl kurios ji idealiai tinka vyrui
Prabanga - tai ne tik ir ne tiek išvaizda. Brangūs drabužiai, kvepalai ir kosmetika neduos laukiamo efekto, jei damos viduje skambės tuštuma ar juoduma....

Skaityti daugiau

05.12.2023 laikas 08:30 2023 m. gruodžio 5 d. horoskopas: ką žada astrologai?
Kiekvienas iš mūsų bent kartą gyvenime susimąstėme apie tai, kas gali nutikti ateityje. Astrologija yra vienas populiariausių ir seniausių mokslų, leidžiančių pažvelgti į ateitį ir gauti tam tikras prognozes. Pažvelkime, ką žada 2023 m. gruodžio 5 d....

Skaityti daugiau

04.12.2023 laikas 22:26 Didžioji Australijos sienos paslaptis
Žiūrint iš palydovo, visa Australija padalinta beveik perpus. Smalsūs turistai, mėginantys juokais prasibrauti per perimetrą, susiduria su rimtomis problemomis. (nuo baudų iki realių kalėjimo bausmių). Žinoma, būtų galima paleisti kvadrokopterį, ar d...

Skaityti daugiau